Recursion Pharmaceuticals, Inc. RXRX Business Segments — Other segment items
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s business segments — other segment items.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s business segments — other segment items?
- Recursion Pharmaceuticals, Inc. (RXRX) reported business segments — other segment items of $13.35M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s business segments — other segment items changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s business segments — other segment items decreased by 41.8% year-over-year, from $22.94M to $13.35M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s business segments — other segment items?
- Over 3 years (2022 to 2025), Recursion Pharmaceuticals, Inc.'s business segments — other segment items has grown at a 18.4% compound annual growth rate (CAGR), from $41.52M to $68.94M.
- What does business segments — other segment items mean?
- Encompasses miscellaneous operational expenses or income items within the segment that do not fall into primary categories like salaries or R&D. Tracking these items is essential for understanding the full cost structure and identifying potential overhead inefficiencies.